(1) Clinical practice guideline for the management of cataract among adults. (2) Updated recommendation #14.

GUIDELINE TITLE
(1) Clinical practice guideline for the management of cataract among adults. (2) Updated recommendation #14.

BIBLIOGRAPHIC SOURCE(S)
Philippine Academy of Ophthalmology. Clinical practice guideline for the management of cataract among adults. Philippines: Philippine Academy of Ophthalmology; 2001. 27 p. [73 references]

Philippine Academy of Ophthalmology. Clinical practice guidelines for the management of cataract among adults. Updated recommendation #14. Philipp J Ophthalmol 2005 Apr-Jun;30(2):95-6. [9 references]

GUIDELINE STATUS
This is the current release of the guideline.

** REGULATORY ALERT **
FDA WARNING/REGULATORY ALERT
Note from the National Guideline Clearinghouse: This guideline references a drug(s) for which important revised regulatory information has been released.

On April 7, 2005, the U.S. Food and Drug Administration (FDA) asked manufacturers of non-prescription (over the counter [OTC]) non-steroidal anti-inflammatory drugs (NSAIDs) to revise their labeling to include more specific information about potential gastrointestinal (GI) and cardiovascular (CV) risks, and information to assist consumers in the safe use of the drugs. See the FDA Web site for more information.

Subsequently, on June 15, 2005, the FDA requested that sponsors of all NSAIDs make labeling changes to their products. FDA recommended proposed labeling for both the prescription and OTC NSAIDs and a medication guide for the entire class of prescription products. See the FDA Web site for more information.

abrir aquí para acceder al documento NGC AHRQ completo:
(1) Clinical practice guideline for the management of cataract among adults. (2) Updated recommendation #14.